Entering text into the input field will update the search result below

Opiant Pharmaceuticals' (OPNT) CEO Roger Crystal on Q4 2020 Results - Earnings Call Transcript

SA Transcripts profile picture
SA Transcripts

Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) Q4 2020 Earnings Conference Call March 4, 2021 4:30 PM ET

Company Participants

Ben Atkins – Vice President-Investor Relations

Roger Crystal – Chief Executive Officer

David O'Toole – Chief Financial Officer

Conference Call Participants

Brandon Folkes – Cantor Fitzgerald

Carl Byrnes – Northland Securities

David Bautz – Zacks


Greetings. Welcome to the Opiant Pharmaceuticals Fourth Quarter and Full Year 2020 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note, this conference is being recorded.

I will now turn the conference over to your host, Ben Atkins, Vice President of Investor Relations. You may begin. Ben Atkins

Ben Atkins

Thank you, operator, and thank you all for joining us this afternoon. With me on today's call, our Chief Executive Officer, Dr. Roger Crystal; and Chief Financial Officer, David O'Toole. This afternoon, Opiant issued a press release announcing financial results and providing a business update for the fourth quarter and full year ended December 31, 2020. Please note that certain information discussed on the call today is covered under the safe harbor provision of the Private Securities Litigation Reform Act. We caution listeners that during this call, Opiant management will be making forward-looking statements.

Actual results could differ materially from those stated or implied by these forward-looking statements due to risks and uncertainties associated with the company's business. These forward-looking statements are qualified by the cautionary statements contained in Opiant's news releases and SEC filings, including in our annual report on Form 10-K for the year ended December 31, 2020, and subsequent filings. This conference call also contains time-sensitive information that is accurate only as of the date of this live broadcast, March 4, 2021. Opiant undertakes no obligation to revise or update any forward-looking statements to reflect events

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!

More on OPNT

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.